{"id":9257,"date":"2024-01-18T20:10:14","date_gmt":"2024-01-18T17:10:14","guid":{"rendered":"https:\/\/urbancare.clinic\/neurotechnology-based-recoverix-treatment-provides-safer-alternative-to-medications-for-stroke-and-ms-patients\/"},"modified":"2024-01-18T20:10:14","modified_gmt":"2024-01-18T17:10:14","slug":"il-trattamento-recoveryix-basato-sulla-neurotecnologia-fornisce-unalternativa-piu-sicura-ai-farmaci-per-i-pazienti-affetti-da-ictus-e-sclerosi-multipla","status":"publish","type":"post","link":"https:\/\/urbancare.clinic\/it\/neurotechnology-based-recoverix-treatment-provides-safer-alternative-to-medications-for-stroke-and-ms-patients\/","title":{"rendered":"Il trattamento RecoveriX basato sulla neurotecnologia fornisce un'alternativa pi\u00f9 sicura ai farmaci per i pazienti affetti da ictus e SM"},"content":{"rendered":"
<\/div>\n

Con il crescente numero di persone che ogni anno soffrono di patologie neurologiche come ictus e sclerosi multipla (SM), la consapevolezza di queste condizioni e di come trattarle o gestirle \u00e8 diventata pi\u00f9 importante. Secondo l'Organizzazione Mondiale della Sanit\u00e0, il rischio di sviluppare un ictus nel corso della vita \u00e8 elevato aumentato di 50% negli ultimi 17 anni<\/span><\/a>, con circa una persona su quattro che dovrebbe subire un ictus nel corso della propria vita. Nel frattempo, quasi 3 milioni di persone <\/span><\/a>hanno la SM in tutto il mondo.<\/p>\n

I pazienti affetti da ictus e SM spesso si ritrovano con una qualit\u00e0 di vita ridotta, a causa della limitazione dei movimenti e della spasticit\u00e0 muscolare, in particolare degli arti. La maggior parte dei farmaci somministrati ai pazienti non sono in grado di ripristinare le funzioni corporee interessate. Questi, invece, possono solo evitare che le condizioni del paziente peggiorino o, nel caso della SM, rallentare il declino del paziente. I farmaci antispastici orali spesso forniscono effetti limitati e pu\u00f2 indurre effetti collaterali<\/span><\/a> come debolezza, confusione e vertigini. In alcuni pazienti vengono iniettate nei muscoli piccole dosi di tossina botulinica (botox) per alleviare la spasticit\u00e0. Questo trattamento \u00e8 efficace solo per circa 12 settimane, prima di dover essere ripetuto, il che pu\u00f2 essere costoso e rischioso.<\/p>\n

A differenza della maggior parte dei farmaci per l\u2019ictus e la SM presenti sul mercato, recuperoX<\/span><\/a>, un trattamento di neuroriabilitazione con interfaccia cervello-computer, ha dimostrato di aiutare nella riabilitazione di colpo<\/span><\/a> E sclerosi multipla<\/span><\/a> pazienti. Sviluppato da una societ\u00e0 con sede in Austria ingegneria medica g.tec<\/span><\/a>, recoveryiX stimola elettricamente gli arti dei pazienti, aiutandoli a ritrovare la funzionalit\u00e0 dopo essere stati compromessi da condizioni neurologiche. Il paziente si siede davanti a un computer mentre indossa una cuffia EEG che legge le onde cerebrali del paziente. Il monitor funge da guida del movimento per gli arti e gli elettrodi collegati agli arti forniscono stimolazione elettrica ai muscoli, provocando la dorsiflessione delle articolazioni. Ogni seduta terapeutica dura circa un'ora, con un blocco di trattamento recupero composto da 25 sedute, idealmente tre volte a settimana.<\/p>\n

Uso ripetuto di recoveryiX <\/span><\/a>ha dimostrato di aiutare i pazienti a recuperare l'uso degli arti, con riduzione della spasticit\u00e0 e miglioramento delle capacit\u00e0 motorie. Ad esempio, questo pu\u00f2 essere dimostrato<\/span><\/a> da una migliore prestazione nel test del picchetto a nove fori, una misura di buona destrezza manuale. I pazienti hanno anche mostrato una migliore concentrazione, prestazione fisica, cognizione, memoria e controllo della vescica. Questi contribuiscono a migliorare la qualit\u00e0 della vita e consentono ai pazienti di svolgere la maggior parte delle attivit\u00e0 che non potrebbero svolgere dopo aver sviluppato un ictus o una SM.<\/p>\n

Secondo il cofondatore e amministratore delegato di g.tec, Dr. Christoph Guger, il recoveryiX, che si basa sulla stimolazione visiva ed elettromuscolare, ha molteplici effetti positivi senza alcun effetto collaterale negativo significativo. Aggiunge che, esaminando gli studi clinici sui farmaci, \u00e8 necessario che migliaia di pazienti dimostrino che il farmaco ha un certo effetto. Poich\u00e9 la sperimentazione clinica prevede test su un gran numero di persone, ci\u00f2 non significa che il farmaco sia ideale per un singolo paziente.<\/p>\n

Inoltre, per la sclerosi multipla si possono utilizzare circa 20 farmaci diversi, a seconda del paziente e del tipo di SM. Dopo un anno di assunzione di un determinato farmaco, il paziente viene valutato se \u00e8 efficace. Se il farmaco non \u00e8 quello giusto per il paziente, c'\u00e8 la possibilit\u00e0 che possa semplicemente peggiorare le cose, dice Guger.<\/p>\n

Nonostante l\u2019enorme impatto positivo dei nuovi trattamenti basati sulla tecnologia come recoveryiX, Guger osserva che i medici a volte possono essere riluttanti a prescriverli. Anche alcune compagnie di assicurazione devono ancora coprire questi trattamenti. Secondo Guger, ci\u00f2 \u00e8 dovuto al fatto che molti medici erano formati esclusivamente sui farmaci e il recoveryiX non esisteva ancora quando frequentavano la facolt\u00e0 di medicina. Tuttavia, con il tempo, ritiene che sempre pi\u00f9 professionisti medici vedranno i vantaggi di recoveryiX e lo combineranno con i loro regimi di farmaci e trattamenti. Inoltre, le compagnie di assicurazione inizieranno a coprire le sessioni di recupero una volta che avranno visto i dati che funziona e si traduce in costi di pagamento assicurativi inferiori.<\/p>\n

Oggi, recoveryiX \u00e8 disponibile in diversi paesi in Europa, Asia-Pacifico, Nord America e Africa e g.tec utilizza un sistema di franchising unico per consentire la rapida diffusione della tecnologia. Guger si batte per garantire che sempre pi\u00f9 persone affette da ictus, sclerosi multipla e altre patologie neurologiche possano accedere a recoveryiX e vederne di persona gli effetti positivi, oltre a spargere la voce ad altre persone che ne hanno bisogno.<\/p>\n

Fonte quotidiana medica<\/a><\/p>\n

","protected":false},"excerpt":{"rendered":"

<\/div>\n

Con il crescente numero di persone che ogni anno soffrono di patologie neurologiche come ictus e sclerosi multipla (SM), la consapevolezza di queste condizioni e di come trattarle o gestirle \u00e8 diventata pi\u00f9 importante. Secondo l'Organizzazione Mondiale della Sanit\u00e0, il rischio di sviluppare un ictus nel corso della vita \u00e8 elevato aumentato di 50% negli ultimi 17 anni<\/span><\/a>, con circa una persona su quattro che dovrebbe subire un ictus nel corso della propria vita. Nel frattempo, quasi 3 milioni di persone <\/span><\/a>hanno la SM in tutto il mondo.<\/p>\n

I pazienti affetti da ictus e SM spesso si ritrovano con una qualit\u00e0 di vita ridotta, a causa della limitazione dei movimenti e della spasticit\u00e0 muscolare, in particolare degli arti. La maggior parte dei farmaci somministrati ai pazienti non sono in grado di ripristinare le funzioni corporee interessate. Questi, invece, possono solo evitare che le condizioni del paziente peggiorino o, nel caso della SM, rallentare il declino del paziente. I farmaci antispastici orali spesso forniscono effetti limitati e pu\u00f2 indurre effetti collaterali<\/span><\/a> come debolezza, confusione e vertigini. In alcuni pazienti vengono iniettate nei muscoli piccole dosi di tossina botulinica (botox) per alleviare la spasticit\u00e0. Questo trattamento \u00e8 efficace solo per circa 12 settimane, prima di dover essere ripetuto, il che pu\u00f2 essere costoso e rischioso.<\/p>\n

A differenza della maggior parte dei farmaci per l\u2019ictus e la SM presenti sul mercato, recuperoX<\/span><\/a>, un trattamento di neuroriabilitazione con interfaccia cervello-computer, ha dimostrato di aiutare nella riabilitazione di colpo<\/span><\/a> E sclerosi multipla<\/span><\/a> pazienti. Sviluppato da una societ\u00e0 con sede in Austria ingegneria medica g.tec<\/span><\/a>, recoveryiX stimola elettricamente gli arti dei pazienti, aiutandoli a ritrovare la funzionalit\u00e0 dopo essere stati compromessi da condizioni neurologiche. Il paziente si siede davanti a un computer mentre indossa una cuffia EEG che legge le onde cerebrali del paziente. Il monitor funge da guida del movimento per gli arti e gli elettrodi collegati agli arti forniscono stimolazione elettrica ai muscoli, provocando la dorsiflessione delle articolazioni. Ogni seduta terapeutica dura circa un'ora, con un blocco di trattamento recupero composto da 25 sedute, idealmente tre volte a settimana.<\/p>\n

Uso ripetuto di recoveryiX <\/span><\/a>ha dimostrato di aiutare i pazienti a recuperare l'uso degli arti, con riduzione della spasticit\u00e0 e miglioramento delle capacit\u00e0 motorie. Ad esempio, questo pu\u00f2 essere dimostrato<\/span><\/a> da una migliore prestazione nel test del picchetto a nove fori, una misura di buona destrezza manuale. I pazienti hanno anche mostrato una migliore concentrazione, prestazione fisica, cognizione, memoria e controllo della vescica. Questi contribuiscono a migliorare la qualit\u00e0 della vita e consentono ai pazienti di svolgere la maggior parte delle attivit\u00e0 che non potrebbero svolgere dopo aver sviluppato un ictus o una SM.<\/p>\n

Secondo il cofondatore e amministratore delegato di g.tec, Dr. Christoph Guger, il recoveryiX, che si basa sulla stimolazione visiva ed elettromuscolare, ha molteplici effetti positivi senza alcun effetto collaterale negativo significativo. Aggiunge che, esaminando gli studi clinici sui farmaci, \u00e8 necessario che migliaia di pazienti dimostrino che il farmaco ha un certo effetto. Poich\u00e9 la sperimentazione clinica prevede test su un gran numero di persone, ci\u00f2 non significa che il farmaco sia ideale per un singolo paziente.<\/p>\n

Inoltre, per la sclerosi multipla si possono utilizzare circa 20 farmaci diversi, a seconda del paziente e del tipo di SM. Dopo un anno di assunzione di un determinato farmaco, il paziente viene valutato se \u00e8 efficace. Se il farmaco non \u00e8 quello giusto per il paziente, c'\u00e8 la possibilit\u00e0 che possa semplicemente peggiorare le cose, dice Guger.<\/p>\n

Nonostante l\u2019enorme impatto positivo dei nuovi trattamenti basati sulla tecnologia come recoveryiX, Guger osserva che i medici a volte possono essere riluttanti a prescriverli. Anche alcune compagnie di assicurazione devono ancora coprire questi trattamenti. Secondo Guger, ci\u00f2 \u00e8 dovuto al fatto che molti medici erano formati esclusivamente sui farmaci e il recoveryiX non esisteva ancora quando frequentavano la facolt\u00e0 di medicina. Tuttavia, con il tempo, ritiene che sempre pi\u00f9 professionisti medici vedranno i vantaggi di recoveryiX e lo combineranno con i loro regimi di farmaci e trattamenti. Inoltre, le compagnie di assicurazione inizieranno a coprire le sessioni di recupero una volta che avranno visto i dati che funziona e si traduce in costi di pagamento assicurativi inferiori.<\/p>\n

Oggi, recoveryiX \u00e8 disponibile in diversi paesi in Europa, Asia-Pacifico, Nord America e Africa e g.tec utilizza un sistema di franchising unico per consentire la rapida diffusione della tecnologia. Guger si batte per garantire che sempre pi\u00f9 persone affette da ictus, sclerosi multipla e altre patologie neurologiche possano accedere a recoveryiX e vederne di persona gli effetti positivi, oltre a spargere la voce ad altre persone che ne hanno bisogno.<\/p>","protected":false},"author":2,"featured_media":9258,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"Default","format":"standard","meta":{"page_builder":"","fifu_image_url":"https:\/\/urbancare.clinic\/wp-content\/uploads\/2024\/01\/neurotechnology-based-recoverix-treatment-provides-safer-alternative-to-medications-for-stroke-and-ms-patients.jpg","fifu_image_alt":"","footnotes":""},"categories":[27],"tags":[],"class_list":["post-9257","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-blog"],"yoast_head":"\nNeurotechnology-Based RecoveriX Treatment Provides Safer Alternative To Medications For Stroke And MS Patients - Urban Care Clinic<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/urbancare.clinic\/it\/il-trattamento-recoveryix-basato-sulla-neurotecnologia-fornisce-unalternativa-piu-sicura-ai-farmaci-per-i-pazienti-affetti-da-ictus-e-sclerosi-multipla\/\" \/>\n<meta property=\"og:locale\" content=\"it_IT\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Neurotechnology-Based RecoveriX Treatment Provides Safer Alternative To Medications For Stroke And MS Patients - Urban Care Clinic\" \/>\n<meta property=\"og:description\" content=\"With more people suffering from neurological conditions such as stroke and multiple sclerosis (MS) each year, awareness of these conditions and how to treat or manage them has become more important. According to the World Health Organization, the lifetime risk of developing a stroke has risen by 50% over the past 17 years, with around one in every four people expected to suffer a stroke in their lifetime. Meanwhile, close to 3 million people have MS worldwide.Stroke and MS patients are often left with a decreased quality of life, due to limited movement and muscle spasticity, particularly in their limbs. Most of the medications given to patients are unable to restore affected bodily functions. Instead, these can only prevent the patient's condition from deteriorating or, in the case of MS, slow down the patient's decline. Oral antispastic medications often provide limited effects and may induce side effects such as weakness, confusion and dizziness. For some patients, small doses of botulinum toxin (botox) are injected into the muscles to relieve the spasticity. This treatment is effective for only around 12 weeks, before it needs to be repeated, which can be both costly and risky.Unlike most medications for stroke and MS on the market, recoveriX, a brain-computer interface neurorehabilitation treatment, has been shown to aid in the rehabilitation of stroke and multiple sclerosis patients. Developed by Austria-based company g.tec medical engineering, recoveriX electrically stimulates patients' limbs, helping them regain function after being impaired by neurological conditions. The patient sits in front of a computer unit while wearing an EEG headset that reads the patient's brainwaves. The monitor serves as a movement guide for their limbs and the electrodes connected to their limbs provide electrical stimulation to muscles, causing dorsiflexion of the joints. Each therapy session lasts for around an hour, with one recoveriX treatment block consisting of 25 sessions, ideally three times a week.Repeated use of recoveriX has been shown to help patients recover the use of their limbs, with reduced spasticity and improved motor skills. For example, this can be demonstrated by better performance in the nine-hole peg test, a measure of fine manual dexterity. Patients have also shown better concentration, physical performance, cognition, memory and bladder control. These contribute to improved quality of life and allow patients to do most of the activities they couldn't after developing stroke or MS.According to g.tec co-founder and CEO, Dr. Christoph Guger, recoveriX, which relies on visual and electro-muscular stimulation has multiple positive effects without any significant negative side effects. He adds that looking at clinical studies for medication, there is a need for thousands of patients to prove that the medication has a certain effect. Because the clinical trial involves testing on a large number of people, this doesn't mean that the medication is ideal for an individual patient.Furthermore, for multiple sclerosis, there are around 20 different medications that can be used, depending on the patient and the type of MS. After one year of taking a certain medication, the patient is evaluated whether it is effective. If the medication isn't the right one for the patient, there is a chance that it could just make things worse, Guger says.Despite the huge positive impact of new, technology-enabled treatments such as recoveriX, Guger notes that doctors can sometimes be hesitant to prescribe them. Some insurance companies, as well, have yet to cover these treatments. According to Guger, this is because many physicians were trained solely on medication and recoveriX did not yet exist when they were in medical school. However, with time, he believes that more medical professionals will see the benefits of recoveriX and combine it with their medication and treatment regimens. Additionally, insurance companies will begin covering recoveriX sessions once they see the data that it works and results in lower insurance payout costs.Today, recoveriX is available in multiple countries across Europe, Asia-Pacific, North America and Africa and g.tec uses a unique franchise system to enable the rapid spread of the technology. Guger is fighting to ensure that more people suffering from stroke, MS and other neurological conditions will be able to access recoveriX and see for themselves its positive effects, as well as spread the word to other people who need it.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/urbancare.clinic\/it\/il-trattamento-recoveryix-basato-sulla-neurotecnologia-fornisce-unalternativa-piu-sicura-ai-farmaci-per-i-pazienti-affetti-da-ictus-e-sclerosi-multipla\/\" \/>\n<meta property=\"og:site_name\" content=\"Urban Care Clinic\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/urbancarezanzibar\" \/>\n<meta property=\"article:published_time\" content=\"2024-01-18T17:10:14+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/urbancare.clinic\/wp-content\/uploads\/2024\/01\/neurotechnology-based-recoverix-treatment-provides-safer-alternative-to-medications-for-stroke-and-ms-patients.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"1024\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Urban Care Clinic\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Scritto da\" \/>\n\t<meta name=\"twitter:data1\" content=\"Urban Care Clinic\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tempo di lettura stimato\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minuti\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/urbancare.clinic\\\/neurotechnology-based-recoverix-treatment-provides-safer-alternative-to-medications-for-stroke-and-ms-patients\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/urbancare.clinic\\\/neurotechnology-based-recoverix-treatment-provides-safer-alternative-to-medications-for-stroke-and-ms-patients\\\/\"},\"author\":{\"name\":\"Urban Care Clinic\",\"@id\":\"https:\\\/\\\/urbancare.clinic\\\/#\\\/schema\\\/person\\\/a304a61bcf298680ee41e2e9ae193930\"},\"headline\":\"Neurotechnology-Based RecoveriX Treatment Provides Safer Alternative To Medications For Stroke And MS Patients\",\"datePublished\":\"2024-01-18T17:10:14+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/urbancare.clinic\\\/neurotechnology-based-recoverix-treatment-provides-safer-alternative-to-medications-for-stroke-and-ms-patients\\\/\"},\"wordCount\":727,\"publisher\":{\"@id\":\"https:\\\/\\\/urbancare.clinic\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/urbancare.clinic\\\/neurotechnology-based-recoverix-treatment-provides-safer-alternative-to-medications-for-stroke-and-ms-patients\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/urbancare.clinic\\\/wp-content\\\/uploads\\\/2024\\\/01\\\/neurotechnology-based-recoverix-treatment-provides-safer-alternative-to-medications-for-stroke-and-ms-patients.jpg\",\"articleSection\":[\"Medical Daily\"],\"inLanguage\":\"it-IT\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/urbancare.clinic\\\/neurotechnology-based-recoverix-treatment-provides-safer-alternative-to-medications-for-stroke-and-ms-patients\\\/\",\"url\":\"https:\\\/\\\/urbancare.clinic\\\/neurotechnology-based-recoverix-treatment-provides-safer-alternative-to-medications-for-stroke-and-ms-patients\\\/\",\"name\":\"Neurotechnology-Based RecoveriX Treatment Provides Safer Alternative To Medications For Stroke And MS Patients - Urban Care Clinic\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/urbancare.clinic\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/urbancare.clinic\\\/neurotechnology-based-recoverix-treatment-provides-safer-alternative-to-medications-for-stroke-and-ms-patients\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/urbancare.clinic\\\/neurotechnology-based-recoverix-treatment-provides-safer-alternative-to-medications-for-stroke-and-ms-patients\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/urbancare.clinic\\\/wp-content\\\/uploads\\\/2024\\\/01\\\/neurotechnology-based-recoverix-treatment-provides-safer-alternative-to-medications-for-stroke-and-ms-patients.jpg\",\"datePublished\":\"2024-01-18T17:10:14+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/urbancare.clinic\\\/neurotechnology-based-recoverix-treatment-provides-safer-alternative-to-medications-for-stroke-and-ms-patients\\\/#breadcrumb\"},\"inLanguage\":\"it-IT\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/urbancare.clinic\\\/neurotechnology-based-recoverix-treatment-provides-safer-alternative-to-medications-for-stroke-and-ms-patients\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"it-IT\",\"@id\":\"https:\\\/\\\/urbancare.clinic\\\/neurotechnology-based-recoverix-treatment-provides-safer-alternative-to-medications-for-stroke-and-ms-patients\\\/#primaryimage\",\"url\":\"https:\\\/\\\/urbancare.clinic\\\/wp-content\\\/uploads\\\/2024\\\/01\\\/neurotechnology-based-recoverix-treatment-provides-safer-alternative-to-medications-for-stroke-and-ms-patients.jpg\",\"contentUrl\":\"https:\\\/\\\/urbancare.clinic\\\/wp-content\\\/uploads\\\/2024\\\/01\\\/neurotechnology-based-recoverix-treatment-provides-safer-alternative-to-medications-for-stroke-and-ms-patients.jpg\",\"caption\":\"Neurotechnology-Based RecoveriX Treatment Provides Safer Alternative To Medications For Stroke And MS Patients\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/urbancare.clinic\\\/neurotechnology-based-recoverix-treatment-provides-safer-alternative-to-medications-for-stroke-and-ms-patients\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/urbancare.clinic\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Neurotechnology-Based RecoveriX Treatment Provides Safer Alternative To Medications For Stroke And MS Patients\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/urbancare.clinic\\\/#website\",\"url\":\"https:\\\/\\\/urbancare.clinic\\\/\",\"name\":\"Urban Care Clinic\",\"description\":\"Your Medical Healthcare Clinic in Zanzibar\",\"publisher\":{\"@id\":\"https:\\\/\\\/urbancare.clinic\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/urbancare.clinic\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"it-IT\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/urbancare.clinic\\\/#organization\",\"name\":\"Urban Care Clinic Zanzibar\",\"alternateName\":\"Urban Care Clinic\",\"url\":\"https:\\\/\\\/urbancare.clinic\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"it-IT\",\"@id\":\"https:\\\/\\\/urbancare.clinic\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/urbancare.clinic\\\/wp-content\\\/uploads\\\/2022\\\/07\\\/Urban-Care-Clinic-Logo-Trans-512x512-1.png\",\"contentUrl\":\"https:\\\/\\\/urbancare.clinic\\\/wp-content\\\/uploads\\\/2022\\\/07\\\/Urban-Care-Clinic-Logo-Trans-512x512-1.png\",\"width\":500,\"height\":500,\"caption\":\"Urban Care Clinic Zanzibar\"},\"image\":{\"@id\":\"https:\\\/\\\/urbancare.clinic\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/urbancarezanzibar\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/urbancare.clinic\\\/#\\\/schema\\\/person\\\/a304a61bcf298680ee41e2e9ae193930\",\"name\":\"Urban Care Clinic\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"it-IT\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8f8b5f9c42679ce61ae24fd31561a4574502595c4b3428a4fdf92d929bf09352?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8f8b5f9c42679ce61ae24fd31561a4574502595c4b3428a4fdf92d929bf09352?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8f8b5f9c42679ce61ae24fd31561a4574502595c4b3428a4fdf92d929bf09352?s=96&d=mm&r=g\",\"caption\":\"Urban Care Clinic\"},\"url\":\"https:\\\/\\\/urbancare.clinic\\\/it\\\/author\\\/urban-care-clinic\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Il trattamento RecoveriX basato sulla neurotecnologia fornisce un'alternativa pi\u00f9 sicura ai farmaci per i pazienti affetti da ictus e SM - Urban Care Clinic","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/urbancare.clinic\/it\/il-trattamento-recoveryix-basato-sulla-neurotecnologia-fornisce-unalternativa-piu-sicura-ai-farmaci-per-i-pazienti-affetti-da-ictus-e-sclerosi-multipla\/","og_locale":"it_IT","og_type":"article","og_title":"Neurotechnology-Based RecoveriX Treatment Provides Safer Alternative To Medications For Stroke And MS Patients - Urban Care Clinic","og_description":"With more people suffering from neurological conditions such as stroke and multiple sclerosis (MS) each year, awareness of these conditions and how to treat or manage them has become more important. According to the World Health Organization, the lifetime risk of developing a stroke has risen by 50% over the past 17 years, with around one in every four people expected to suffer a stroke in their lifetime. Meanwhile, close to 3 million people have MS worldwide.Stroke and MS patients are often left with a decreased quality of life, due to limited movement and muscle spasticity, particularly in their limbs. Most of the medications given to patients are unable to restore affected bodily functions. Instead, these can only prevent the patient's condition from deteriorating or, in the case of MS, slow down the patient's decline. Oral antispastic medications often provide limited effects and may induce side effects such as weakness, confusion and dizziness. For some patients, small doses of botulinum toxin (botox) are injected into the muscles to relieve the spasticity. This treatment is effective for only around 12 weeks, before it needs to be repeated, which can be both costly and risky.Unlike most medications for stroke and MS on the market, recoveriX, a brain-computer interface neurorehabilitation treatment, has been shown to aid in the rehabilitation of stroke and multiple sclerosis patients. Developed by Austria-based company g.tec medical engineering, recoveriX electrically stimulates patients' limbs, helping them regain function after being impaired by neurological conditions. The patient sits in front of a computer unit while wearing an EEG headset that reads the patient's brainwaves. The monitor serves as a movement guide for their limbs and the electrodes connected to their limbs provide electrical stimulation to muscles, causing dorsiflexion of the joints. Each therapy session lasts for around an hour, with one recoveriX treatment block consisting of 25 sessions, ideally three times a week.Repeated use of recoveriX has been shown to help patients recover the use of their limbs, with reduced spasticity and improved motor skills. For example, this can be demonstrated by better performance in the nine-hole peg test, a measure of fine manual dexterity. Patients have also shown better concentration, physical performance, cognition, memory and bladder control. These contribute to improved quality of life and allow patients to do most of the activities they couldn't after developing stroke or MS.According to g.tec co-founder and CEO, Dr. Christoph Guger, recoveriX, which relies on visual and electro-muscular stimulation has multiple positive effects without any significant negative side effects. He adds that looking at clinical studies for medication, there is a need for thousands of patients to prove that the medication has a certain effect. Because the clinical trial involves testing on a large number of people, this doesn't mean that the medication is ideal for an individual patient.Furthermore, for multiple sclerosis, there are around 20 different medications that can be used, depending on the patient and the type of MS. After one year of taking a certain medication, the patient is evaluated whether it is effective. If the medication isn't the right one for the patient, there is a chance that it could just make things worse, Guger says.Despite the huge positive impact of new, technology-enabled treatments such as recoveriX, Guger notes that doctors can sometimes be hesitant to prescribe them. Some insurance companies, as well, have yet to cover these treatments. According to Guger, this is because many physicians were trained solely on medication and recoveriX did not yet exist when they were in medical school. However, with time, he believes that more medical professionals will see the benefits of recoveriX and combine it with their medication and treatment regimens. Additionally, insurance companies will begin covering recoveriX sessions once they see the data that it works and results in lower insurance payout costs.Today, recoveriX is available in multiple countries across Europe, Asia-Pacific, North America and Africa and g.tec uses a unique franchise system to enable the rapid spread of the technology. Guger is fighting to ensure that more people suffering from stroke, MS and other neurological conditions will be able to access recoveriX and see for themselves its positive effects, as well as spread the word to other people who need it.","og_url":"https:\/\/urbancare.clinic\/it\/il-trattamento-recoveryix-basato-sulla-neurotecnologia-fornisce-unalternativa-piu-sicura-ai-farmaci-per-i-pazienti-affetti-da-ictus-e-sclerosi-multipla\/","og_site_name":"Urban Care Clinic","article_publisher":"https:\/\/www.facebook.com\/urbancarezanzibar","article_published_time":"2024-01-18T17:10:14+00:00","og_image":[{"url":"https:\/\/urbancare.clinic\/wp-content\/uploads\/2024\/01\/neurotechnology-based-recoverix-treatment-provides-safer-alternative-to-medications-for-stroke-and-ms-patients.jpg","width":1024,"height":1024,"type":"image\/jpeg"}],"author":"Urban Care Clinic","twitter_card":"summary_large_image","twitter_misc":{"Scritto da":"Urban Care Clinic","Tempo di lettura stimato":"4 minuti"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/urbancare.clinic\/neurotechnology-based-recoverix-treatment-provides-safer-alternative-to-medications-for-stroke-and-ms-patients\/#article","isPartOf":{"@id":"https:\/\/urbancare.clinic\/neurotechnology-based-recoverix-treatment-provides-safer-alternative-to-medications-for-stroke-and-ms-patients\/"},"author":{"name":"Urban Care Clinic","@id":"https:\/\/urbancare.clinic\/#\/schema\/person\/a304a61bcf298680ee41e2e9ae193930"},"headline":"Neurotechnology-Based RecoveriX Treatment Provides Safer Alternative To Medications For Stroke And MS Patients","datePublished":"2024-01-18T17:10:14+00:00","mainEntityOfPage":{"@id":"https:\/\/urbancare.clinic\/neurotechnology-based-recoverix-treatment-provides-safer-alternative-to-medications-for-stroke-and-ms-patients\/"},"wordCount":727,"publisher":{"@id":"https:\/\/urbancare.clinic\/#organization"},"image":{"@id":"https:\/\/urbancare.clinic\/neurotechnology-based-recoverix-treatment-provides-safer-alternative-to-medications-for-stroke-and-ms-patients\/#primaryimage"},"thumbnailUrl":"https:\/\/urbancare.clinic\/wp-content\/uploads\/2024\/01\/neurotechnology-based-recoverix-treatment-provides-safer-alternative-to-medications-for-stroke-and-ms-patients.jpg","articleSection":["Medical Daily"],"inLanguage":"it-IT"},{"@type":"WebPage","@id":"https:\/\/urbancare.clinic\/neurotechnology-based-recoverix-treatment-provides-safer-alternative-to-medications-for-stroke-and-ms-patients\/","url":"https:\/\/urbancare.clinic\/neurotechnology-based-recoverix-treatment-provides-safer-alternative-to-medications-for-stroke-and-ms-patients\/","name":"Il trattamento RecoveriX basato sulla neurotecnologia fornisce un'alternativa pi\u00f9 sicura ai farmaci per i pazienti affetti da ictus e SM - Urban Care Clinic","isPartOf":{"@id":"https:\/\/urbancare.clinic\/#website"},"primaryImageOfPage":{"@id":"https:\/\/urbancare.clinic\/neurotechnology-based-recoverix-treatment-provides-safer-alternative-to-medications-for-stroke-and-ms-patients\/#primaryimage"},"image":{"@id":"https:\/\/urbancare.clinic\/neurotechnology-based-recoverix-treatment-provides-safer-alternative-to-medications-for-stroke-and-ms-patients\/#primaryimage"},"thumbnailUrl":"https:\/\/urbancare.clinic\/wp-content\/uploads\/2024\/01\/neurotechnology-based-recoverix-treatment-provides-safer-alternative-to-medications-for-stroke-and-ms-patients.jpg","datePublished":"2024-01-18T17:10:14+00:00","breadcrumb":{"@id":"https:\/\/urbancare.clinic\/neurotechnology-based-recoverix-treatment-provides-safer-alternative-to-medications-for-stroke-and-ms-patients\/#breadcrumb"},"inLanguage":"it-IT","potentialAction":[{"@type":"ReadAction","target":["https:\/\/urbancare.clinic\/neurotechnology-based-recoverix-treatment-provides-safer-alternative-to-medications-for-stroke-and-ms-patients\/"]}]},{"@type":"ImageObject","inLanguage":"it-IT","@id":"https:\/\/urbancare.clinic\/neurotechnology-based-recoverix-treatment-provides-safer-alternative-to-medications-for-stroke-and-ms-patients\/#primaryimage","url":"https:\/\/urbancare.clinic\/wp-content\/uploads\/2024\/01\/neurotechnology-based-recoverix-treatment-provides-safer-alternative-to-medications-for-stroke-and-ms-patients.jpg","contentUrl":"https:\/\/urbancare.clinic\/wp-content\/uploads\/2024\/01\/neurotechnology-based-recoverix-treatment-provides-safer-alternative-to-medications-for-stroke-and-ms-patients.jpg","caption":"Neurotechnology-Based RecoveriX Treatment Provides Safer Alternative To Medications For Stroke And MS Patients"},{"@type":"BreadcrumbList","@id":"https:\/\/urbancare.clinic\/neurotechnology-based-recoverix-treatment-provides-safer-alternative-to-medications-for-stroke-and-ms-patients\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/urbancare.clinic\/"},{"@type":"ListItem","position":2,"name":"Neurotechnology-Based RecoveriX Treatment Provides Safer Alternative To Medications For Stroke And MS Patients"}]},{"@type":"WebSite","@id":"https:\/\/urbancare.clinic\/#website","url":"https:\/\/urbancare.clinic\/","name":"Clinica Urbanistica","description":"La tua clinica sanitaria medica a Zanzibar","publisher":{"@id":"https:\/\/urbancare.clinic\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/urbancare.clinic\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"it-IT"},{"@type":"Organization","@id":"https:\/\/urbancare.clinic\/#organization","name":"Clinica Urban Care Zanzibar","alternateName":"Urban Care Clinic","url":"https:\/\/urbancare.clinic\/","logo":{"@type":"ImageObject","inLanguage":"it-IT","@id":"https:\/\/urbancare.clinic\/#\/schema\/logo\/image\/","url":"https:\/\/urbancare.clinic\/wp-content\/uploads\/2022\/07\/Urban-Care-Clinic-Logo-Trans-512x512-1.png","contentUrl":"https:\/\/urbancare.clinic\/wp-content\/uploads\/2022\/07\/Urban-Care-Clinic-Logo-Trans-512x512-1.png","width":500,"height":500,"caption":"Urban Care Clinic Zanzibar"},"image":{"@id":"https:\/\/urbancare.clinic\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/urbancarezanzibar"]},{"@type":"Person","@id":"https:\/\/urbancare.clinic\/#\/schema\/person\/a304a61bcf298680ee41e2e9ae193930","name":"Clinica Urbanistica","image":{"@type":"ImageObject","inLanguage":"it-IT","@id":"https:\/\/secure.gravatar.com\/avatar\/8f8b5f9c42679ce61ae24fd31561a4574502595c4b3428a4fdf92d929bf09352?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/8f8b5f9c42679ce61ae24fd31561a4574502595c4b3428a4fdf92d929bf09352?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/8f8b5f9c42679ce61ae24fd31561a4574502595c4b3428a4fdf92d929bf09352?s=96&d=mm&r=g","caption":"Urban Care Clinic"},"url":"https:\/\/urbancare.clinic\/it\/author\/urban-care-clinic\/"}]}},"_links":{"self":[{"href":"https:\/\/urbancare.clinic\/it\/wp-json\/wp\/v2\/posts\/9257","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/urbancare.clinic\/it\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/urbancare.clinic\/it\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/urbancare.clinic\/it\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/urbancare.clinic\/it\/wp-json\/wp\/v2\/comments?post=9257"}],"version-history":[{"count":0,"href":"https:\/\/urbancare.clinic\/it\/wp-json\/wp\/v2\/posts\/9257\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/urbancare.clinic\/it\/wp-json\/wp\/v2\/media\/9258"}],"wp:attachment":[{"href":"https:\/\/urbancare.clinic\/it\/wp-json\/wp\/v2\/media?parent=9257"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/urbancare.clinic\/it\/wp-json\/wp\/v2\/categories?post=9257"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/urbancare.clinic\/it\/wp-json\/wp\/v2\/tags?post=9257"}],"curies":[{"name":"scrivere","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}